Parkinson's disease and brain mitochondrial dysfunction: a functional phosphorus magnetic resonance spectroscopy...

Area of Science:

• Neuroscience
• Biochemistry
• Medical Imaging

Background:

• Mitochondrial impairment is suspected in Parkinson's disease (PD), but in vivo evidence in the human brain is lacking.
• Previous research established 31 phosphorus magnetic resonance spectroscopy (31P MRS) for studying mitochondrial function in neurological conditions.

Purpose of the Study:

• To investigate in vivo mitochondrial dysfunction in the visual cortex of Parkinson's disease patients using 31P MRS.
• To assess brain energetics and intracellular pH during visual activation and recovery in PD patients compared to controls.

Main Methods:

• Utilized high-resolution 31P MRS to measure high-energy phosphates (HEPs) and intracellular pH (pH).
• Studied 20 PD patients and 20 healthy controls at rest, during, and after visual activation.
• Analyzed changes in HEPs and pH to infer mitochondrial function and brain energetics.

Main Results:

• Normal subjects showed stable HEPs during activation, a 16% rise during recovery, and increased pH.
• PD patients exhibited normal resting HEPs but a significant 36% fall in HEPs during recovery.
• Intracellular pH in PD patients showed a heterogeneous pattern, indicating varied subclinical brain involvement.

Conclusions:

• The study demonstrates in vivo mitochondrial dysfunction in the PD brain, particularly evident during the post-activation recovery phase.
• This dysfunction occurs even without overt clinical symptoms, highlighting subclinical brain involvement.
• 31P MRS combined with brain activation is a valuable tool for PD diagnostics and monitoring therapeutic interventions.